Softcure Opthalmics Private Limited
About Softcure Opthalmics Private Limited
Data last updated:
Softcure Opthalmics Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2017PTC090517. Its GSTIN is 09AAYCS1551R1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Kripa Shankar Srivastava and Prem Lata Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sa 5/129 – G – 2 – M Chitragupt Nagar Colony Ramreypur, Varanasi, Uttar Pradesh, India – 221007.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.29 Lakh, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹11,931 (net margin -0.4%) and EBITDA of ₹27,813 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Softcure Opthalmics Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSa 5/129 – G – 2 – M Chitragupt Nagar Colony Ramreypur, Varanasi, Uttar Pradesh, India – 221007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Softcure Opthalmics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Softcure Opthalmics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Softcure Opthalmics Private Limited, buy the company report.
Financials of Softcure Opthalmics Private Limited
FY 2025 filings availableSoftcure Opthalmics Private Limited reported revenue of ₹31.29 Lakh (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 21% growth in the latest year. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27,813 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹11,931 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Softcure Opthalmics Private Limited, buy the company report.
Board of directors of Softcure Opthalmics Private Limited
Softcure Opthalmics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kripa Shankar Srivastava | Director | 17 Feb 2017 | 9 Years 8 Months | Current |
| Prem Lata Srivastava | Director | 25 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Softcure Opthalmics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gen Saai Farmacio Private Limited | ₹31.71 Lakh (FY 2022) | Thrissur, Kerala, India | ||||
| Aayusiddhi Life Sciences Private Limited | ₹31.42 Lakh (FY 2017) | -24.0% | Hyderabad, Telangana, India | |||
| Softcure Opthalmics Private Limitedthis company | ₹31.29 Lakh (FY 2025) | -₹11,931 | -0.4% | 21.0% | Varanasi, Uttar Pradesh, India | |
| Kontiki Chemicals and Pharmaceuticals Pvt Ltd | ₹31.16 Lakh (FY 2025) | 5.0% | Kannur, Kerala, India | |||
| Valcambi Private Limited | ₹31.02 Lakh (FY 2025) | 32.0% | Manmad, Maharashtra, India |
To see the full peer comparison of Softcure Opthalmics Private Limited, buy the company report.
Auditor
Softcure Opthalmics Private Limited is audited by KRISHNA ANURAG & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHNA ANURAG & CO | FY 2019 | 010146C |
Shareholding
The shareholding of Softcure Opthalmics Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Softcure Opthalmics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Softcure Opthalmics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Softcure Opthalmics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Softcure Opthalmics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAYCS1551R1Z9 | Uttar Pradesh | Active | 09 Sep 2017 |
To see the full GST registrations and return filing status of Softcure Opthalmics Private Limited, buy the company report.
Recent activity
Softcure Opthalmics Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Sudhir Kumar Srivastava ceased to be Director on 19 Sep 2025.
Frequently asked questions
Softcure Opthalmics is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2017 (9+ years old) and is registered under CIN U24304UP2017PTC090517.
Softcure Opthalmics has 2 current directors:
- Kripa Shankar Srivastava - Director
- Prem Lata Srivastava - Director
The latest financial statements of Softcure Opthalmics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Softcure Opthalmics is 09AAYCS1551R1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Softcure Opthalmics is U24304UP2017PTC090517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Softcure Opthalmics was incorporated on 17 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Softcure Opthalmics by revenue are Gen Saai Farmacio Private Limited, Aayusiddhi Life Sciences Private Limited, Kontiki Chemicals and Pharmaceuticals Pvt Ltd, Valcambi Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sudhir Kumar Srivastava ceased to be Director on 19 Sep 2025. Prem Lata Srivastava was appointed as Director on 25 Feb 2025. Kripa Shankar Srivastava was appointed as Director on 17 Feb 2017. Softcure Opthalmics has 4 board changes on record in total.
The registered office of Softcure Opthalmics is at Sa 5129 – G – 2 – M Chitragupt Nagar Colony Ramreypur, Varanasi, Uttar Pradesh, India – 221007.
Softcure Opthalmics operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Softcure Opthalmics is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
